Search research articles
Contact Us
Filters
Showing results (231-240 of 252) with videos related to
Page
of 26
Sort By:
Ophthalmology. Retina
|
May 4, 2019
Long-Term Assessment of Macular Atrophy in Patients with Age-Related Macular Degeneration Receiving Anti-Vascular Endothelial Growth Factor
Ang Li, Nathaniel B Rieveschl, Felipe F Conti, et al.
Ophthalmology
|
February 9, 2024
Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity of < 20/40
Chirag D Jhaveri, Danni Liu, Maureen G Maguire, et al.
JAMA
|
December 15, 2020
Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical Trial
Andrew N Antoszyk, Adam R Glassman, Wesley T Beaulieu, et al.
JAMA
|
May 1, 2019
Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial
Carl W Baker, Adam R Glassman, Wesley T Beaulieu, et al.
JAMA Ophthalmology
|
March 30, 2021
Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial
Raj K Maturi, Adam R Glassman, Kristin Josic, et al.
JAMA
|
February 7, 2023
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy
Raj K Maturi, Adam R Glassman, Kristin Josic, et al.
Ophthalmology
|
May 14, 2021
Pneumatic Vitreolysis with Perfluoropropane for Vitreomacular Traction with and without Macular Hole: DRCR Retina Network Protocols AG and AH
Clement K Chan, Calvin E Mein, Adam R Glassman, et al.
JAMA Ophthalmology
|
August 18, 2022
Association of Predominantly Peripheral Lesions on Ultra-Widefield Imaging and the Risk of Diabetic Retinopathy Worsening Over Time
Dennis M Marcus, Paolo S Silva, Danni Liu, et al.
JAMA Ophthalmology
|
August 18, 2022
Association of Ultra-Widefield Fluorescein Angiography-Identified Retinal Nonperfusion and the Risk of Diabetic Retinopathy Worsening Over Time
Paolo S Silva, Dennis M Marcus, Danni Liu, et al.
Ophthalmology. Retina
|
October 10, 2021
A Randomized Trial of Photobiomodulation Therapy for Center-Involved Diabetic Macular Edema with Good Visual Acuity (Protocol AE)
Judy E Kim, Adam R Glassman, Kristin Josic, et al.
Page
of 26
Search research articles
Search
Showing results (231-240 of 252) with videos related to
Sort By:
Page
of 26
Ophthalmology. Retina
|
May 4, 2019
Long-Term Assessment of Macular Atrophy in Patients with Age-Related Macular Degeneration Receiving Anti-Vascular Endothelial Growth Factor
Ang Li, Nathaniel B Rieveschl, Felipe F Conti, et al.
Ophthalmology
|
February 9, 2024
Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity of < 20/40
Chirag D Jhaveri, Danni Liu, Maureen G Maguire, et al.
JAMA
|
December 15, 2020
Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical Trial
Andrew N Antoszyk, Adam R Glassman, Wesley T Beaulieu, et al.
JAMA
|
May 1, 2019
Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial
Carl W Baker, Adam R Glassman, Wesley T Beaulieu, et al.
JAMA Ophthalmology
|
March 30, 2021
Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial
Raj K Maturi, Adam R Glassman, Kristin Josic, et al.
JAMA
|
February 7, 2023
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy
Raj K Maturi, Adam R Glassman, Kristin Josic, et al.
Ophthalmology
|
May 14, 2021
Pneumatic Vitreolysis with Perfluoropropane for Vitreomacular Traction with and without Macular Hole: DRCR Retina Network Protocols AG and AH
Clement K Chan, Calvin E Mein, Adam R Glassman, et al.
JAMA Ophthalmology
|
August 18, 2022
Association of Predominantly Peripheral Lesions on Ultra-Widefield Imaging and the Risk of Diabetic Retinopathy Worsening Over Time
Dennis M Marcus, Paolo S Silva, Danni Liu, et al.
JAMA Ophthalmology
|
August 18, 2022
Association of Ultra-Widefield Fluorescein Angiography-Identified Retinal Nonperfusion and the Risk of Diabetic Retinopathy Worsening Over Time
Paolo S Silva, Dennis M Marcus, Danni Liu, et al.
Ophthalmology. Retina
|
October 10, 2021
A Randomized Trial of Photobiomodulation Therapy for Center-Involved Diabetic Macular Edema with Good Visual Acuity (Protocol AE)
Judy E Kim, Adam R Glassman, Kristin Josic, et al.
Page
of 26